Sildenafil and Big Pharma: A Precarious Investment ?

The story of Viagra, and its creator copyright, presents a complex case study for investors. At first a blockbuster drug, producing billions in income, its patent expiration created a deluge of knock-off medications, significantly diminishing its market share . While some pharmaceutical companies may attempt to capitalize on related treatments , th

read more